Search Results - Shengxia Yin

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody

    Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody by Ruifei Xue, Jian Wang, Jie Zhan, Zhiyi Zhang, Suling Jiang, Jiacheng Liu, Li Wang, Xiaomin Yan, Shengxia Yin, Xin Tong, Weimao Ding, Jie Li, Yuxin Chen, Rui Huang, Chao Wu

    Published 2025-12-01

    The clinical significance of the coexistence of hepatitis B e antigen (HBeAg) and antibodies against HBeAg (anti-HBe) in patients with chronic hepatitis B (CHB) remains unclear. This study investigated the clinical features and phase transition of patients with coexisting HBeAg/anti-HBe. A total of...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment

    The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment by Shengxia Yin, Yawen Wan, Rahma Issa, Yijia Zhu, Xiaoming Xu, Jiacheng Liu, Minxin Mao, Ming Li, Xin Tong, Chen Tian, Jian Wang, Rui Huang, Qun Zhang, Chao Wu, Yuxin Chen, Jie Li

    Published 2023-12-01

    Indices for predicting HBsAg or HBeAg seroconversion in patients with chronic hepatitis B virus (HBV) infection during antiviral therapy remain elusive. We aimed to investigate if the presence of HBsAb-specific B cells at baseline can predict HBsAg or HBeAg seroconversion. In this study, 134 treatme...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: